BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 15862412)

  • 1. Ventricular assist device therapy normalizes inducible nitric oxide synthase expression and reduces cardiomyocyte apoptosis in the failing human heart.
    Patten RD; Denofrio D; El-Zaru M; Kakkar R; Saunders J; Celestin F; Warner K; Rastegar H; Khabbaz KR; Udelson JE; Konstam MA; Karas RH
    J Am Coll Cardiol; 2005 May; 45(9):1419-24. PubMed ID: 15862412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide overproduction derived from inducible nitric oxide synthase increases cardiomyocyte apoptosis in human atrial fibrillation.
    Han W; Fu S; Wei N; Xie B; Li W; Yang S; Li Y; Liang Z; Huo H
    Int J Cardiol; 2008 Nov; 130(2):165-73. PubMed ID: 18585800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered myocardial Ca2+ cycling after left ventricular assist device support in the failing human heart.
    Chaudhary KW; Rossman EI; Piacentino V; Kenessey A; Weber C; Gaughan JP; Ojamaa K; Klein I; Bers DM; Houser SR; Margulies KB
    J Am Coll Cardiol; 2004 Aug; 44(4):837-45. PubMed ID: 15312868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of beta3-adrenoreceptors agonist on beta3-adrenoreceptors expression and myocyte apoptosis in a rat model of heart failure].
    Kong YH; Li WM; Tian Y
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Mar; 16(3):142-7. PubMed ID: 15009959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global gene expression analysis in nonfailing and failing myocardium pre- and postpulsatile and nonpulsatile ventricular assist device support.
    Schwientek P; Ellinghaus P; Steppan S; D'Urso D; Seewald M; Kassner A; Cebulla R; Schulte-Eistrup S; Morshuis M; Röfe D; El Banayosy A; Körfer R; Milting H
    Physiol Genomics; 2010 Aug; 42(3):397-405. PubMed ID: 20460602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiomyocyte survivin protein expression is associated with cell size and DNA content in the failing human heart and is reversibly regulated after ventricular unloading.
    Wohlschlaeger J; Meier B; Schmitz KJ; Takeda A; Takeda N; Vahlhaus C; Levkau B; Stypmann J; Schmid C; Schmid KW; Baba HA
    J Heart Lung Transplant; 2010 Nov; 29(11):1286-92. PubMed ID: 20851637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescence imaging microscopy of cellular markers in ischemic vs non-ischemic cardiomyopathy after left ventricular unloading.
    Bick RJ; Bagwell SH; Jones CE; Poindexter BJ; Buja LM; Youker KA; Grigore A; Clubb F; Radovancevic B; Frazier OH
    J Heart Lung Transplant; 2005 Apr; 24(4):454-61. PubMed ID: 15797748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The structural examination of myocardial samples from patients with end-stage heart failure supported by ventricular assist devices using electron microscopy and amino acid analysis reveals low degree of reverse remodeling.
    Milting H; Jacob M; Kassner A; Heimann P; Mannherz HG; Becker G; Meyer HE; Böthig D; Arusoglu L; Morshuis M; Körfer R; El Banayosy A
    J Heart Lung Transplant; 2004 Apr; 23(4):396-404. PubMed ID: 15063398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inducible nitric oxide synthase (iNOS) in the human heart: expression and localization in congestive heart failure.
    Vejlstrup NG; Bouloumie A; Boesgaard S; Andersen CB; Nielsen-Kudsk JE; Mortensen SA; Kent JD; Harrison DG; Busse R; Aldershvile J
    J Mol Cell Cardiol; 1998 Jun; 30(6):1215-23. PubMed ID: 9689595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of angiotensin-converting enzyme inhibitor therapy on the extracellular collagen matrix during left ventricular assist device support in patients with end-stage heart failure.
    Klotz S; Danser AH; Foronjy RF; Oz MC; Wang J; Mancini D; D'Armiento J; Burkhoff D
    J Am Coll Cardiol; 2007 Mar; 49(11):1166-74. PubMed ID: 17367660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of constitutive nitric oxide synthase III, but not inducible nitric oxide synthase II, in human heart failure.
    Stein B; Eschenhagen T; Rüdiger J; Scholz H; Förstermann U; Gath I
    J Am Coll Cardiol; 1998 Nov; 32(5):1179-86. PubMed ID: 9809923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteopontin: a potential biomarker for heart failure and reverse remodeling after left ventricular assist device support.
    Schipper ME; Scheenstra MR; van Kuik J; van Wichen DF; van der Weide P; Dullens HF; Lahpor J; de Jonge N; De Weger RA
    J Heart Lung Transplant; 2011 Jul; 30(7):805-10. PubMed ID: 21531579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic beta-adrenergic receptor stimulation induces cardiac apoptosis and aggravates myocardial ischemia/reperfusion injury by provoking inducible nitric-oxide synthase-mediated nitrative stress.
    Hu A; Jiao X; Gao E; Koch WJ; Sharifi-Azad S; Grunwald Z; Ma XL; Sun JZ
    J Pharmacol Exp Ther; 2006 Aug; 318(2):469-75. PubMed ID: 16574780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The apoptosis and its relationship with the expression of inducible nitric oxide synthase and Bcl-2 proteins in prostate carcinoma].
    Xu M; Li S; Zheng X; Hu L
    Zhonghua Nan Ke Xue; 2004 Jan; 10(1):39-41. PubMed ID: 14979207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inducible nitric oxide synthase in severe human heart failure: impact of mechanical unloading.
    Starling RC
    J Am Coll Cardiol; 2005 May; 45(9):1425-7. PubMed ID: 15862413
    [No Abstract]   [Full Text] [Related]  

  • 16. Ischemic preconditioning upregulates inducible nitric oxide synthase in cardiac myocyte.
    Wang Y; Guo Y; Zhang SX; Wu WJ; Wang J; Bao W; Bolli R
    J Mol Cell Cardiol; 2002 Jan; 34(1):5-15. PubMed ID: 11812160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic support by left ventricular assist devices reduces cardiomyocyte DNA content in the failing human heart.
    Wohlschlaeger J; Levkau B; Brockhoff G; Schmitz KJ; von Winterfeld M; Takeda A; Takeda N; Stypmann J; Vahlhaus C; Schmid C; Pomjanski N; Böcking A; Baba HA
    Circulation; 2010 Mar; 121(8):989-96. PubMed ID: 20159834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocyte nitric oxide synthase 2 contributes to blunted beta-adrenergic response in failing human hearts by decreasing Ca2+ transients.
    Ziolo MT; Maier LS; Piacentino V; Bossuyt J; Houser SR; Bers DM
    Circulation; 2004 Apr; 109(15):1886-91. PubMed ID: 15037528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of iNOS-derived reactive nitrogen species and resultant nitrative stress in leukocytes-induced cardiomyocyte apoptosis after myocardial ischemia/reperfusion.
    Wang XL; Liu HR; Tao L; Liang F; Yan L; Zhao RR; Lopez BL; Christopher TA; Ma XL
    Apoptosis; 2007 Jul; 12(7):1209-17. PubMed ID: 17333318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide depresses connexin 43 after myocardial infarction in mice.
    Jackson PE; Feng QP; Jones DL
    Acta Physiol (Oxf); 2008 Sep; 194(1):23-33. PubMed ID: 18394025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.